에스티팜 'CMO'로 팬데믹 장애 돌파 — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

Media Focus

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

Media Focus

Sep 3, 2020

에스티팜 'CMO'로 팬데믹 장애 돌파

- 올해 하반기부터 수주 본격화 전망

[기사 원문 보기]

http://www.econovill.com/news/articleView.html?idxno=410455